UK scientists have unearthed a link between paracetamol use and asthma risk, saying that the antioxidant genes of the mothers and child impacts the way that paracetamol use can impact future health of a child.
In the study, 14,000 children were studied from their pregnancy until their 8th year of life by a team led by Seif Shaheen, Professor of Respiratory Epidemiology at Barts and The London School of Medicine and Dentistry.
Mothers were asked about instances of using paracetamol during their pregnancy and also if and when children were administered paracetamol during infancy.
As to the extent to which paracetamol use impacted a child’s asthma risk, this was seen to be dependent upon the antioxidant gene variations that were seen to be present in the mother.
The researchers said that randomized clinical trials were required to confirm this premise, however this research, which was published in the Journal of Allergy and Clinical Immunology seemed to add further credence to the theory that prenatal paracetamol exposure impacts the way in which the development of childhood asthma occurs.